As E4orf4 induces a p53-independent, non-canonical programmed cell death [23,24,25] and a large percent of human tumors are p53-deficient [33], investigation of the unique mode of E4orf4-induced cancer cell killing may have exciting implications for cancer therapy. The gene discussed is TP53; the disease is cancer.